1 min read
Add as a preferred source on Google

OraSure Pushes Operating Cash Flow Breakeven to Second Half of 2027

The company expects $30 million to $32 million in revenue for Q4 2026, with gross margin near or slightly below its third-quarter level.

A glass hourglass stands before an unmarked diagnostic test kit. / TokenPost.ai
A glass hourglass stands before an unmarked diagnostic test kit. / TokenPost.ai

OraSure Technologies, Inc. now expects to reach operating cash flow breakeven in the second half of 2027, moving back a milestone it had previously expected at the start of 2027.

The company projects revenue of $30 million to $32 million for Q4 2026. It expects gross margin to be similar to or slightly below its third-quarter level. In the third quarter, OraSure expanded gross margins and reduced operating spending.

OraSure’s Ebola 2.0 test received emergency use authorization, and the company fulfilled initial orders. Its Colli-Pee Dx product has also launched.

John Kim

John Kim reports on the digital-asset business for TokenPost. Send corrections or tips to info@tokenpost.com.

Loading…